NIH VideoCast - Nanolayered drug-release systems for regenerative medicine and targeted nanotherapies

Skip Navigation

Nanolayered drug-release systems for regenerative medicine and targeted nanotherapies

Loading... Loading video...

311 Views

Air date:	Thursday, May 26, 2016, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 311 (82 Live, 229 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:08:59
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director's Wednesday Afternoon Lecture Series Margaret Pittman Lecture Alternating electrostatic assembly is a tool that makes it possible to create ultrathin film coatings that contain highly controlled quantities of one or more therapeutic molecules within a singular construct. These release systems greatly exceed the usual ranges of traditional degradable polymers. The nature of the layering process enables the incorporation of different drugs within different regions of the thin-film architecture; the result is an ability to uniquely tailor both the independent-release profiles and order-of-release of each therapeutic to the targeted region of the body. The Hammond lab has demonstrated the use of this approach to release or present signaling molecules such as growth factors and small-interfering RNA (siRNA) and DNA to regulate genes to facilitate tissue regeneration in situ for orthopedic implants, address soft-tissue wound healing, deliver vaccines from microneedle surfaces, or administer targeted nanotherapies that are highly synergistic for cancer treatments. Professor Paula T. Hammond is the David H. Koch Chair Professor of Engineering in the Chemical Engineering Department at the Massachusetts Institute of Technology and a member of MIT’s Koch Institute for Integrative Cancer Research. The core of her work is the use of electrostatics and other complementary interactions to generate functional polymer materials with highly controlled architecture. Her research in nanotechnology encompasses the development of new biomaterials to enable drug delivery from surfaces with spatio-temporal control. She also investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery, and self-assembled materials systems for regenerative medicine. This annual lecture honors Dr. Margaret Pittman, NIH's first female lab chief, who made significant contributions to microbiology and vaccine development, particularly in the areas of pertussis and tetanus, during her long career at the National Institute of Allergy and Infectious Diseases. For more information go to https://oir.nih.gov/wals

NLM Title:	Nanolayered drug-release systems for regenerative medicine and targeted nanotherapies / Paula T. Hammond.
Author:	Hammond, Paula T. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director's Wednesday Afternoon Lecture Series Margaret Pittman Lecture Alternating electrostatic assembly is a tool that makes it possible to create ultrathin film coatings that contain highly controlled quantities of one or more therapeutic molecules within a singular construct. These release systems greatly exceed the usual ranges of traditional degradable polymers. The nature of the layering process enables the incorporation of different drugs within different regions of the thin-film architecture; the result is an ability to uniquely tailor both the independent-release profiles and order-of-release of each therapeutic to the targeted region of the body. The Hammond lab has demonstrated the use of this approach to release or present signaling molecules such as growth factors and small-interfering RNA (siRNA) and DNA to regulate genes to facilitate tissue regeneration in situ for orthopedic implants, address soft-tissue wound healing, deliver vaccines from microneedle surfaces, or administer targeted nanotherapies that are highly synergistic for cancer treatments. Professor Paula T. Hammond is the David H. Koch Chair Professor of Engineering in the Chemical Engineering Department at the Massachusetts Institute of Technology and a member of MIT's Koch Institute for Integrative Cancer Research. The core of her work is the use of electrostatics and other complementary interactions to generate functional polymer materials with highly controlled architecture. Her research in nanotechnology encompasses the development of new biomaterials to enable drug delivery from surfaces with spatio-temporal control. She also investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery, and self-assembled materials systems for regenerative medicine. This annual lecture honors Dr. Margaret Pittman, NIH's first female lab chief, who made significant contributions to microbiology and vaccine development, particularly in the areas of pertussis and tetanus, during her long career at the National Institute of Allergy and Infectious Diseases.
Subjects:	Coated Materials, Biocompatible Drug Carriers Drug Delivery Systems Nanoparticles--therapeutic use
Publication Types:	Lecture Webcast

NLM Classification:	QV 785
NLM ID:	101684413
CIT Live ID:	18979
Permanent link:	https://videocast.nih.gov/watch=18979

Related Videos...